Delivery Order SPE2DB24D1205-SPE2DB25FDANY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,690.07 to AmerisourceBergen Drug Corp for Tolvaptan 15 mg tablets in unit dose packaging. This non-competitive delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price transaction for pharmaceutical supply. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging on September 9, 2025. This competitively awarded, non-set-aside contract is valued at $15,578.98 and requires completion by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, under a firm fixed-price arrangement typical of delivery orders against existing...
- The Defense Logistics Agency awarded a delivery order valued at $15,233.64 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 15 mg tablets in unit dose packaging of 10s. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price pricing and represents a child delivery order issued under a...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packaging (10-count). The contract carries a ceiling value of $181,808 under a firm fixed-price arrangement with a completion date of July 15, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with the Defense Logistics Agency Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Tolvaptan 15 mg tablets in unit dose packages of 10 units. This is a firm fixed-price delivery order with a ceiling value of $5,100.87 and an ultimate completion date of July 18, 2025. The contract was awarded on a competitive basis without any set-aside designation. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tolvaptan 15 mg tablets. The contract has a ceiling value of $7,674.04 and a period of performance running through March 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $24,520.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that provides Tolvaptan 15 mg tablets to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for the company to supply a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $55,282.57, is for the delivery of 4567618547 TOLVAPTAN 30 MG TABLET UD 10S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 19, 2025. The contract does not have a set-aside designation, indicating open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOLVAPTAN 15 MG TABLET UD 10S, a medication, with a ceiling value of $13,468.19 and a performance period ending on May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a delivery order under contract SPE2DX15D1022 with the Defense Logistics Agency (DLA) Troop Support Medical. The $36,811.80 firm fixed price award is for the supply of tolvaptan 15 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FDANYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,092.55 to AmerisourceBergen Drug Corp for the supply of Tolvaptan 30 mg tablets in unit dose packaging (10-count units). This firm fixed price contract, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major healthcare solutions provider and pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and the Defense Health Agency worldwide. AmerisourceBergen's demonstrated capability to compete successfully for federal medical supply contracts, combined with its substantial IDC, positions the company as a critical vendor for fulfilling pharmaceutical requirements across the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 9/16/25 |